◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › R › RVTY

Revvity Inc. (RVTY) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-19

Revvity Inc. (RVTY) operates in the Health Care Equipment industry and is headquartered in Waltham, United States with about 11,000 employees. Its market capitalization is roughly $16 billion. In the fiscal year ended 2025-12-31, RVTY reported $2.9B in revenue and $242M in net income.

Revvity, Inc. provides health sciences solutions, technologies, and services.

Interactive charts & full statements → Open the RVTY valuation workbench →

RVTY Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$2.9B	$2.9B	$2.8B	$2.8B	$3.3B	$3.8B	$3.8B	$2.9B	$2.8B	$2.3B	$2.1B	$2.1B	$2.2B	$2.2B	$2.1B	$1.9B	$1.7B	$1.6B	$2.0B	$1.8B	$1.5B
Gross Profit	$1.5B	$1.5B	$1.3B	$1.3B	$1.8B	$2.3B	$2.0B	$1.3B	$1.3B	$1.0B	$972M	$930M	$971M	$940M	$924M	$824M	$740M	$699M	$835M	$715M	$623M
Gross Margin %	52.1%	53.1%	48.0%	48.1%	53.2%	59.6%	52.6%	44.8%	45.0%	45.6%	46.0%	44.2%	43.4%	43.4%	43.7%	42.9%	43.4%	45.1%	42.6%	40.0%	40.3%
Operating Income (EBIT)	$358M	$357M	$411M	$399M	$781M	$1.3B	$1.0B	$405M	$371M	$305M	$306M	$267M	$230M	$259M	$201M	$118M	$173M	$140M	$201M	$175M	$152M
Operating Margin %	12.3%	12.5%	14.9%	14.5%	23.6%	35.0%	27.0%	14.1%	13.4%	13.5%	14.4%	12.7%	10.3%	11.9%	9.5%	6.1%	10.1%	9.0%	10.3%	9.8%	9.8%
Net Income	$238M	$242M	$296M	($118M)	$569M	$943M	$728M	$228M	$239M	$113M	$234M	$212M	$158M	$168M	$68M	$1M	$384M	$86M	$128M	$133M	$117M
Net Margin %	8.2%	8.5%	10.7%	-4.3%	17.2%	24.6%	19.2%	7.9%	8.6%	5.0%	11.1%	10.1%	7.1%	7.8%	3.2%	0.1%	22.5%	5.5%	6.6%	7.4%	7.6%
EBITDA	—	$663M	$840M	$714M	$1.2B	$1.6B	$1.2B	$515M	$505M	$446M	$386M	$352M	$323M	$332M	$223M	$200M	$267M	$201M	$263M	$245M	$229M
Earnings Per Share (EPS)	$2.09	$2.13	$2.41	$-0.95	$4.50	$8.08	$6.50	$2.04	$2.14	$1.02	$2.12	$1.87	$1.39	$1.48	$0.60	$0.01	$3.25	$0.73	$1.08	$1.10	$0.93
Shares Outstanding (M)	—	113M	123M	125M	126M	117M	112M	112M	112M	111M	110M	113M	114M	114M	115M	114M	118M	117M	119M	121M	126M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RVTY Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$730M	$711M	$772M	$699M	$720M	$665M	$729M	$684M	$692M
Gross Profit	$417M	$388M	$338M	$375M	$393M	$376M	$360M	$385M	$386M
Gross Margin %	57.1%	54.5%	43.8%	53.6%	54.5%	56.5%	49.3%	56.3%	55.7%
Operating Income (EBIT)	$88M	$76M	$112M	$82M	$91M	$72M	$132M	$103M	$102M
Operating Margin %	12.0%	10.7%	14.5%	11.7%	12.6%	10.9%	18.1%	15.0%	14.7%
Net Income	$52M	$41M	$98M	$47M	$55M	$42M	$95M	$94M	$79M
Net Margin %	7.1%	5.7%	12.7%	6.7%	7.7%	6.3%	13.0%	13.7%	11.4%
EBITDA	—	$180M	$218M	$181M	$194M	$173M	$222M	$232M	$219M
Earnings Per Share (EPS)	$0.46	$0.36	$0.87	$0.40	$0.47	$0.35	$0.78	$0.76	$0.64
Shares Outstanding (M)	—	112M	113M	118M	118M	120M	122M	123M	123M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RVTY Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$629M	$582M	$628M	$91M	$680M	$1.4B	$892M	$363M	$311M	$288M	$351M	$287M	$282M	$159M	$152M	$225M	$164M	$149M	$218M	$205M	$127M
Capital Expenditures (CapEx)	$70M	$74M	$87M	$81M	$86M	$100M	$78M	$81M	$93M	$39M	$32M	$30M	$29M	$39M	$42M	$31M	$34M	$32M	$43M	$47M	$44M
Free Cash Flow (FCF)	$559M	$508M	$542M	$10M	$594M	$1.3B	$815M	$282M	$218M	$249M	$319M	$257M	$253M	$120M	$110M	$194M	$131M	$117M	$175M	$158M	$83M
FCF Margin %	19.2%	17.8%	19.7%	0.4%	17.9%	34.2%	21.5%	9.8%	7.8%	11.1%	15.1%	12.2%	11.3%	5.5%	5.2%	10.1%	7.7%	7.5%	8.9%	8.8%	5.4%
Dividends Paid	—	$33M	$34M	$35M	$35M	$32M	$31M	$31M	$31M	$31M	$31M	$32M	$32M	$32M	$32M	$32M	$33M	$33M	$33M	$34M	$35M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RVTY Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$192M	$115M	$183M	$139M	$134M	$128M	$174M	$148M	$159M
Capital Expenditures (CapEx)	$11M	$20M	$20M	$19M	$19M	$16M	$24M	$22M	$22M
Free Cash Flow (FCF)	$181M	$95M	$163M	$120M	$115M	$112M	$150M	$126M	$137M
FCF Margin %	24.8%	13.4%	21.1%	17.2%	16.0%	16.9%	20.5%	18.4%	19.8%
Dividends Paid	—	$8M	$8M	$8M	$8M	$8M	$9M	$9M	$9M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RVTY Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$12.0B	$12.2B	$12.4B	$13.6B	$14.1B	$15.0B	$8.0B	$6.5B	$6.0B	$6.1B	$4.3B	$4.2B	$4.1B	$3.9B	$3.9B	$3.9B	$3.2B	$3.1B	$2.9B	$2.9B	$2.5B
Cash & Cash Equivalents	$1.0B	$920M	$1.2B	$913M	$454M	$603M	$402M	$192M	$163M	$202M	$359M	$238M	$175M	$173M	$171M	$142M	$420M	$180M	$179M	$203M	$191M
Total Liabilities	$4.8B	$4.9B	$4.7B	$5.7B	$6.7B	$7.9B	$4.2B	$3.7B	$3.4B	$3.6B	$2.1B	$2.1B	$2.1B	$2.0B	$2.0B	$2.0B	$1.3B	$1.4B	$1.4B	$1.4B	$933M
Total Debt (Short + Long-Term)	$3.3B	$3.2B	$3.2B	$3.9B	$4.4B	$5.0B	$2.0B	$2.1B	$16M	$217M	$1M	$1M	$1M	$3M	$2M	($138M)	$2M	$0M	$0M	$1M	$1M
Total Shareholders' Equity	$7.2B	$7.2B	$7.7B	$7.9B	$7.4B	$7.1B	$3.7B	$2.8B	$2.6B	$2.5B	$2.2B	$2.1B	$2.0B	$2.0B	$1.9B	$1.8B	$1.9B	$1.6B	$1.6B	$1.6B	$1.6B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RVTY viewer.

RVTY Metric Deep Dives

Other Companies in Health Care Equipment

RMD · ResMed — $32 billion
GEHC · GE HealthCare — $29 billion
STE · Steris — $20 billion
ZBH · Zimmer Biomet — $18 billion
BAX · Baxter International — $12 billion
PODD · Insulet Corporation — $10 billion
ABT · Abbott Laboratories — $178 billion
ISRG · Intuitive Surgical — $141 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← RVTH All “R” companies RVX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.